Renaissance Technologies’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-76,581
Closed -$5.51M 3616
2024
Q3
$5.51M Buy
+76,581
New +$5.4M 0.01% 1385
2020
Q2
Sell
-201,981
Closed -$11.6M 3476
2020
Q1
$11.6M Buy
201,981
+155,700
+336% +$14.4M 0.01% 1079
2019
Q4
$5.18M Buy
+46,281
New +$4.93M ﹤0.01% 1831
2019
Q1
Sell
-82,681
Closed -$5.31M 3471
2018
Q4
$5.31M Buy
82,681
+46,900
+131% +$3.21M 0.01% 1692
2018
Q3
$2.83M Buy
+35,781
New +$2.77M ﹤0.01% 2107
2018
Q2
Sell
-41,781
Closed -$2.65M 3288
2018
Q1
$2.65M Buy
41,781
+22,781
+120% +$1.36M ﹤0.01% 2175
2017
Q4
$968K Buy
19,000
+7,700
+68% +$401K ﹤0.01% 2668
2017
Q3
$593K Buy
+11,300
New +$567K ﹤0.01% 2743
2017
Q2
Sell
-42,481
Closed -$1.89M 3203
2017
Q1
$1.89M Buy
+42,481
New +$1.83M ﹤0.01% 2272
2016
Q3
Sell
-49,081
Closed -$2.34M 3343
2016
Q2
$2.34M Sell
49,081
-54,700
-53% -$2.32M ﹤0.01% 2111
2016
Q1
$4.35M Buy
103,781
+61,300
+144% +$2.41M 0.01% 1731
2015
Q4
$1.87M Buy
42,481
+21,381
+101% +$928K ﹤0.01% 2155
2015
Q3
$1.01M Buy
+21,100
New +$1.16M ﹤0.01% 2375
2014
Q4
Sell
-180,481
Closed -$6.65M 2973
2014
Q3
$6.65M Sell
180,481
-30,279
-14% -$1.2M 0.02% 1019
2014
Q2
$9.3M Buy
210,760
+165,079
+361% +$7.49M 0.02% 888
2014
Q1
$1.99M Buy
+45,681
New +$2.04M ﹤0.01% 1774
2013
Q4
Sell
-74,181
Closed -$2.52M 2863
2013
Q3
$2.52M Sell
74,181
-24,500
-25% -$799K 0.01% 1552
2013
Q2
$3.08M Buy
+98,681
New +$3.2M 0.01% 1350

Other funds holding CNMD

Renaissance Technologies's CNMD Position: Q4 2024 in Review

Renaissance Technologies sold out of CONMED (CNMD) in Q4 2024, closing a stake of 76,581 shares — an estimated $5.51M sold.

Renaissance Technologies first reported a position in CNMD in Q2 2013 and held it in 18 quarters. The position peaked at $11.6M in Q1 2020. 280 funds tracked by Wall St. Rank hold CNMD as of Q4 2024.

  • Renaissance Technologies reported no remaining CONMED position as of Q4 2024 after selling out during the quarter.
  • Renaissance Technologies sold 76,581 CONMED shares in Q4 2024, an estimated $5.51M.
  • Renaissance Technologies first reported a position in CONMED in Q2 2013 and held it in 18 quarters.
  • Renaissance Technologies's CONMED position peaked at $11.6M in Q1 2020.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q4 2024.

Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.